Our Services
Medical Information
Helpful Resources
Published on: 9/15/2026
Fatigue is one of the most common side effects of metoprolol, and for many people it does ease within a few days to several weeks as the body adjusts to a slower heart rate and lower blood pressure. Tiredness that persists beyond a month, worsens, or comes with dizziness, shortness of breath, very slow pulse, or depressed mood may signal a dose that is too high or another underlying issue that needs review. Dose timing, gradual titration, thyroid problems, anemia, sleep apnea, and interactions with other medications can all influence how long the fatigue lasts. There are several important factors and warning signs to consider before assuming it will simply pass, so see below to understand more, and never stop metoprolol abruptly, since sudden withdrawal can trigger chest pain or dangerous rhythm changes.
Because ongoing fatigue can stem from your medication, your heart condition, or something entirely separate, it helps to sort out the likely cause before your next appointment: take a free, instant, online symptom check to see which explanations best fit your situation and what steps to discuss with your prescriber.
Last reviewed for medical accuracy: 09/14/2026
Metoprolol is a widely prescribed beta-blocker used to manage high blood pressure, angina (chest pain) and certain heart rhythm disorders. While it effectively reduces the workload on your heart and helps prevent heart attacks, one of the most common side effects people report is tiredness or fatigue. It’s natural to wonder: does the tiredness from metoprolol go away over time?
Drawing on data from sources such as the U.S. Food and Drug Administration (FDA) prescribing information, clinical guidelines and large patient surveys, here’s what you need to know.
Metoprolol works by blocking beta-adrenergic receptors in your heart and blood vessels. This slows your heart rate and lowers blood pressure. While that’s beneficial, it also slows down some of your body’s normal “get-up-and-go” signals. Common factors contributing to metoprolol-related fatigue include:
Reduced heart rate and cardiac output
With a slower heartbeat, less blood and oxygen circulate to muscles and the brain, which can leave you feeling sluggish.
Central nervous system effects
Beta-blockers can cross into the brain and slightly dampen the central nervous system, contributing to general lethargy.
Adjustment period
Your body needs time—often several days to a few weeks—to adapt to new levels of beta-blockade.
Dose-related impact
Higher doses of metoprolol (especially immediate-release forms) tend to cause more pronounced fatigue.
Your personal response to metoprolol can differ based on:
While metoprolol-related tiredness often diminishes on its own, you can take proactive steps to support your energy level:
While most metoprolol-related tiredness is temporary and harmless, certain warnings apply:
If you experience any of the above symptoms, speak to a healthcare professional promptly. You might also consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help clarify your next steps.
Metoprolol remains a cornerstone treatment for many cardiovascular conditions because it:
While fatigue can be frustrating, it’s important to weigh this against the significant protective effects on your heart and blood vessels. In most cases, the tiredness subsides as your body adjusts, often within a month or two.
Understanding that metoprolol-related tiredness usually lessens over time can provide reassurance. However, every individual is different. If you find fatigue continues to impact your quality of life, or if you notice any serious symptoms, don’t hesitate to speak to your doctor. They can adjust your treatment, run any necessary tests or discuss alternative therapies. When in doubt, always seek medical advice for anything that could be life-threatening or serious.
(References)
* Blomqvist I, Westergren G, Sandberg A, Jonsson UE, Lundborg P. Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol. Eur J Clin Pharmacol. 1988;33 Suppl:S19-24. doi: 10.1007/BF00578408. PMID: 3371390.
* Helton MR. Diagnosis and Management of Common Types of Supraventricular Tachycardia. Am Fam Physician. 2015 Nov 1;92(9):793-800. PMID: 26554472.
* Samuels C, Koenig MK, Hernandez M, Yadav A, Mosquera RA. Mitochondrial Disorder Aggravated by Metoprolol. Case Rep Pediatr. 2016;2016:7869174. doi: 10.1155/2016/7869174. Epub 2016 Oct 20. PMID: 27840760; PMCID: PMC5093265.
* Beta Adrenergic Blocking Agents. 2012. PMID: 31643457.
* Shah R, Babar A, Patel A, Dortonne R, Jordan J. Metoprolol-Associated Central Nervous System Complications. Cureus. 2020 May 22;12(5):e8236. doi: 10.7759/cureus.8236. Epub 2020 May 22. PMID: 32582495; PMCID: PMC7306637.
* Zhu F, Wang Q, Wang Z, Zhang X, Zhang B, Wang H. Metoprolol Mitigates Ischemic Heart Remodeling and Fibrosis by Increasing the Expression of AKAP5 in Ischemic Heart. Oxid Med Cell Longev. 2022;2022:5993459. doi: 10.1155/2022/5993459. Epub 2022 Oct 4. PMID: 36238650; PMCID: PMC9553363.
* Messinger-Rapport B, Grubb B. Patient-Centered Paradigm for Managing Autonomic Long COVID Symptoms During Sports and Exercise. Clin J Sport Med. 2023 Mar 1;33(2):e14-e15. doi: 10.1097/JSM.0000000000001093. Epub 2022 Nov 6. PMID: 36730755.
* Yadav A, Yadav RK, Neyaz O, Sherin P P S, Gupta A. Postural Orthostatic Tachycardia Syndrome in Spinal Cord Injury. Cureus. 2023 Jun;15(6):e41124. doi: 10.7759/cureus.41124. Epub 2023 Jun 29. PMID: 37519618; PMCID: PMC10382909.
* Frustaci A, Borghetti V, Pentiricci S, Verardo R, Scialla R, Russo MA. Hypertrophic obstructive cardiomyopathy caused by Fabry disease: implications for surgical myectomy. ESC Heart Fail. 2023 Dec;10(6):3710-3713. doi: 10.1002/ehf2.14427. Epub 2023 Sep 15. PMID: 37715354; PMCID: PMC10682850.
* Seo K, Yamamoto Y, Kirillova A, Kawana M, Yadav S, Huang Y, Wang Q, Lane KV, Pruitt BL, Perez MV, Bernstein D, Wu JC, Wheeler MT, Parikh VN, Ashley EA. Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-β-Blocking R-Enantiomer Carvedilol. Circulation. 2023 Nov 21;148(21):1691-1704. doi: 10.1161/CIRCULATIONAHA.123.065017. Epub 2023 Oct 18. PMID: 37850394.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.